ArticleCardiovascular diabetology2015

Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.

Lili Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.